C12Y 103/01014
Dihydroorotate dehydrogenase
Official title: Dihydroorotate dehydrogenase (NAD+) (1.3.1.14)
C12Y103/01014 (Dihydroorotate dehydrogenase) appears on 0 US grants and 2 published applications in this corpus.
Search patents in C12Y- Granted patents
- 0
- Published applications
- 2
- Assignees
- 2
- Inventors
- 3
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
By publication year.
Recent patents
No granted patents in this class yet.
- Composition for removing pluripotent stem cells and method of removing pluripotent stem cells17 Nov 2022US 2022/0364065 A1National University Corporation Hokkaido University
- Methods of determining dosing of a therapeutic agent based on measured levels of a metabolite26 Sep 2019US 2019/0290892 A1Clear Creek Bio, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.